Cargando…
A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex
BACKGROUND: Epidermolysis bullosa simplex (EBS) comprises a group of rare, blistering genodermatoses. Prior work has been limited by small sample sizes, and much remains unexplored about the disease burden and health-related quality of life (QOL) of patients with EBS. The aim of this study was to ch...
Autores principales: | So, Jodi Y., Fulchand, Shivali, Wong, Christine Y., Li, Shufeng, Nazaroff, Jaron, Gorell, Emily S., de Souza, Mark P., Murrell, Dedee F., Teng, Joyce M., Chiou, Albert S., Tang, Jean Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287948/ https://www.ncbi.nlm.nih.gov/pubmed/35841105 http://dx.doi.org/10.1186/s13023-022-02433-3 |
Ejemplares similares
-
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
por: So, Jodi Y., et al.
Publicado: (2022) -
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa
por: Tang, Jean Yuh, et al.
Publicado: (2021) -
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023) -
Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals
por: Ramirez-Quizon, Mae, et al.
Publicado: (2021) -
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
por: Rogers, Clare L., et al.
Publicado: (2021)